🔎 Trials Near Me

홈 › 폐암 › 알래스카

알래스카의 폐암 임상 시험

폐암 관련 연구 7개가 알래스카 내 여러 지역에서 참여자를 모집하고 있습니다.

알래스카의 도시

공식 연구 텍스트(영어)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Fairbanks Memorial Hospital, Fairbanks
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • 외 3개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Alaska Oncology and Hematology LLC, Anchorage
  • Katmai Oncology Group, Anchorage
  • Fairbanks Memorial Hospital, Fairbanks
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT04181060

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Alaska Oncology and Hematology, LLC, Anchorage
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06712316

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • Alaska Oncology and Hematology, Anchorage
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06793215

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Katmai Oncology Group, Anchorage
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Katmai Oncology Group, Anchorage
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.